Suppressive effects of procaterol on expression of IP-10/CXCL 10 and RANTES/CCL 5 by bronchial epithelial cells

Inflammation

Volumn 34, Issue 4, 2011, Pages 238-246

  Lam, Ka Pan ^a,d   Chu, Yu Te ^b,d   Kuo, Chang Hung ^b,c,d   Wang, Wei Li ^b,d   Tok, Teck Siang ^a   Chin, Yow Yue ^a   Chen, Solomon Chih Cheng ^a   Hung, Chih Hsing ^b,c,d  

^a PINGTUNG CHRISTIAN HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MUNICIPAL TA TUNG HOSPITAL   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

bronchial epithelial cells; bronchodilators; CCL chemokines; CXCL chemokines; short acting 2 agonist

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; BETA 2 ADRENERGIC RECEPTOR; BUCLADESINE; CYCLIC AMP; GAMMA INTERFERON INDUCIBLE PROTEIN 10; I KAPPA B; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; POLYINOSINIC POLYCYTIDYLIC ACID; PROCATEROL; RANTES; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ARTICLE; BETA ADRENERGIC STIMULATION; CELLULAR DISTRIBUTION; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; BLOTTING, WESTERN; BRONCHI; BUCLADESINE; CELL LINE; CHEMOKINE CCL5; CHEMOKINE CXCL10; EIF-2 KINASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; POLY I-C; PROCATEROL; PROPANOLAMINES; SIGNAL TRANSDUCTION;

EID: 79961172902     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-010-9229-9     Document Type: Article

References (28)

1. WM van Aalderen AB Sprikkelman MO Hoekstra 1999 Is childhood asthma an inflammatory disease? Allergy 54 (Suppl 49) 62 67 10422750 10.1111/j.1398-9995. 1999.tb04390.x (Pubitemid 29292495)
2. JA Woodfolk 2007 T-cell responses to allergens The Journal of Allergy and Clinical Immunology 119 280 294 17291848 10.1016/j.jaci.2006.11.008 1:CAS:528:DC%2BD2sXhs1Ciurs%3D (Pubitemid 46204819)
3. PJ Barnes KF Chung CP Page 1998 Inflammatory mediators of asthma: An update Pharmacological Reviews 50 515 596 9860804 1:CAS:528:DyaK1MXltFyhsA%3D%3D (Pubitemid 29028812)
4. M Akdis CA Akdis 2007 Mechanisms of allergen-specific immunotherapy The Journal of Allergy and Clinical Immunology 119 780 789 17321578 10.1016/j.jaci.2007.01.022 1:CAS:528:DC%2BD2sXjvFaks7k%3D (Pubitemid 46527830)
5. DW Cockcroft BE Davis 2006 Mechanisms of airway hyperresponsiveness The Journal of Allergy and Clinical Immunology 118 551 559 16950269 10.1016/j.jaci.2006.07.012 1:CAS:528:DC%2BD28XpsVWmtr0%3D (Pubitemid 44301418)
6. HF Rosenberg S Phipps PS Foster 2007 Eosinophil trafficking in allergy and asthma The Journal of Allergy and Clinical Immunology 119 1303 1310 17481712 10.1016/j.jaci.2007.03.048 1:CAS:528:DC%2BD2sXmtlaisLg%3D (Pubitemid 46855872)
7. S Tamura T Kurata 2004 Defense mechanisms against influenza virus infection in the respiratory tract mucosa Japanese Journal of Infectious Diseases 57 236 247 15623947 (Pubitemid 40260238)
8. SJ Ono T Nakamura D Miyazaki M Ohbayashi M Dawson M Toda 2003 Chemokines: Roles in leukocyte development, trafficking, and effector function The Journal of Allergy and Clinical Immunology 111 1185 1199 12789214 10.1067/mai.2003.1594 1:CAS:528:DC%2BD3sXkvFGhur4%3D (Pubitemid 36683666)
9. N Zimmermann GK Hershey PS Foster ME Rothenberg 2003 Chemokines in asthma: Cooperative between chemokines & IL-13 The Journal of Allergy and Clinical Immunology 111 227 242 12589338 10.1067/mai.2003.139 1:CAS:528:DC%2BD3sXitVyrt7s%3D (Pubitemid 36228539)
10. WW Busse RF Lemanske 2001 Asthma The New England Journal of Medicine 344 350 362 11172168 10.1056/NEJM200102013440507 1:CAS:528:DC%2BD3MXht1Wlu7k%3D (Pubitemid 32107645)
11. S Qin JB Rottman P Myers N Kassam M Weinblatt M Loetscher AE Koch B Moser CR Mackay 1998 The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions Journal of Clinical Investigation 101 746 754 9466968 10.1172/JCI1422 1:CAS:528:DyaK1cXht1Wrsbk%3D (Pubitemid 28096070)
12. BD Medoff A Sauty AM Tager JA Maclean RN Smith A Mathew JH Dufour AD Luster 2002 IFN-gamma-inducible protein 10 (CXCL10) contributes to airway hyperreactivity and airway inflammation in a mouse model of asthma Journal of Immunology 168 5278 5286 1:CAS:528:DC%2BD38XjslSjtbs%3D (Pubitemid 34495996)
13. PA Wark F Bucchieri SL Johnston PG Gibson L Hamilton J Mimica G Zummo ST Holgate J Attia A Thakkinstian DE Davies 2007 IFN-gamma-induced protein 10 is a novel biomarker of rhinovirus-induced asthma exacerbations The Journal of Allergy and Clinical Immunology 120 586 593 17628646 10.1016/j.jaci.2007.04.046 1:CAS:528:DC%2BD2sXhtVSgsLfL (Pubitemid 47320759)
14. ST Lai CH Hung YM Hua SH Hsu YJ Jong JL Suen 2008 T-helper 1-related chemokines in the exacerbation of childhood asthma Pediatrics International 50 99 102 18279215 10.1111/j.1442-200X.2007.02533.x 1:CAS:528:DC%2BD1cXktlOntL0%3D (Pubitemid 351239413)
15. ED Bateman SS Hurd PJ Barnes J Bousquet JM Drazen M FitzGerald P Gibson K Ohta P O'Byrne SE Pedersen E Pizzichini SD Sullivan SE Wenzel HJ Zar 2008 Global strategy for asthma management and prevention: GINA executive summary The European Respiratory Journal 31 143 178 18166595 10.1183/09031936.00138707 1:CAS:528:DC%2BD1cXhvVCgsL8%3D
16. HS Nelson 2006 Is there a problem with inhaled long-acting beta-adrenergic agonists? The Journal of Allergy and Clinical Immunology 117 3 16 16387577 10.1016/j.jaci.2005.10.013 1:CAS:528:DC%2BD28XktlWq (Pubitemid 43017130)
17. JJ Smucny CA Flynn LA Becker RH Glazier 2001 Are beta2-agonists effective treatment for acute bronchitis or acute cough in patients without underlying pulmonary disease? A systemic review The Journal of Family Practice 50 945 951 11711010 1:STN:280:DC%2BD3MnmslSktQ%3D%3D (Pubitemid 33064984)
18. M Ritter D Mennerich A Weith P Seither 2005 Characterization of Toll-like receptors in primary lung epithelial cells: Strong impact of the TLR3 ligand poly(I:C) on the regulation of Toll-like receptors, adaptor proteins and inflammatory response J Inflamm (Lond) 2 16 10.1186/1476-9255-2-16 (Pubitemid 41803272)
19. NC Stowell J Seideman HA Raymond KA Smalley RJ Lamb DD Egenolf PJ Bugelski LA Murray PA Marsters RA Bunting RA Flavell L Alexopoulou LR San Mateo DE Griswold RT Sarisky ML Mbow AM Das 2009 Long-term activation of TLR3 by poly(I:C) induces inflammation and impairs lung function in mice Respiratory Research 10 43 19486528 10.1186/1465-9921-10-43
20. J Bérubé C Bourdon Y Yao S Rousseau 2009 Distinct intracellular signaling pathways control the synthesis of IL-8 and RANTES in TLR1/TLR2, TLR3 or NOD1 activated human airway epithelial cells Cellular Signalling 21 448 456 19121387 10.1016/j.cellsig.2008.12.001
21. MP Hallsworth CH Twort TH Lee SJ Hirst 2001 Beta 2-adrenoceptor agonists inhibit release of eosinophil activating cytokines from human airway smooth muscle cells British Journal of Pharmacology 132 729 741 11159726 10.1038/sj.bjp.0703866 1:CAS:528:DC%2BD3MXhtlOktrk%3D (Pubitemid 32165189)
22. S Koyama E Sato T Masubuchi A Takamizawa K Kubo S Nagai T Isumi 1999 Procaterol inhibits IL-1beta- and TNF-alpha-mediated epithelial cell eosinophil chemotactic activity The European Respiratory Journal 14 767 775 10573218 10.1034/j.1399-3003.1999.14d07.x 1:CAS:528:DyaK1MXnvVaqtr4%3D (Pubitemid 29519334)
23. H Tashimo N Yamashita H Ishida H Nagase T Adachi J Nakano K Yamamura T Yano H Yoshihara K Ohta 2007 Effect of procaterol, a beta(2) selective adrenergic receptor agonist, on airway inflammation and hyperresponsiveness Allergology International 56 241 247 17582211 10.2332/allergolint.O-06-456 1:CAS:528:DC%2BD2sXhtFCgs7bF (Pubitemid 47442391)
24. S Horikoshi F Kokubu M Adachi 1996 Anti-allergic effects of beta-adrenoceptor agonists in the clinical pharmacological studies Nippon Rinsho 54 3068 3072 8950956 1:STN:280:DyaK2s7gvVKgsg%3D%3D
25. Tomerak, A.A., H. Vyas, M. Lakenpaul, J.J. McGlashan, and M. McKean. 2005. Inhaled beta2-agonists for treating non-specific chronic cough in children. Cochrane Database Syst Rev. CD005373.
26. P Bradding I Rushby J Scullion MD Morgan 1999 As-required versus regular neubulized salbutamol for the treatment of acute severe asthma The European Respiratory Journal 13 290 294 10065670 10.1034/j.1399-3003.1999.13b12.x 1:STN:280:DyaK1M7mtlGmsQ%3D%3D (Pubitemid 29086822)
27. MJ Kemper E Harps HH Hellwege DE Müller-Wiefel 1996 Effective treatment of acute hyperkalaemia in childhood by short-term infusion of salbutamol European Journal of Pediatrics 155 495 497 8789768 10.1007/BF01955188 1:CAS:528:DyaK28Xkt1ehs70%3D (Pubitemid 26171582)
28. E Helfrich TW de Vries EN van Roon 2001 Salbutamol for hyperkalaemia in children Acta Paediatrica 90 1213 1216 11808886 10.1111/j.1651-2227.2001. tb01562.x 1:STN:280:DC%2BD38%2FotFylsA%3D%3D (Pubitemid 33149725)